Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · March 08, 2023

Efficacy and Safety of Colesevelam for the Treatment of Bile Acid Diarrhoea

The Lancet Gastroenterology & Hepatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Gastroenterology & Hepatology
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial
Lancet Gastroenterol Hepatol 2023 Feb 06;[EPub Ahead of Print], C Borup, L Vinter-Jensen, SPG Jørgensen, S Wildt, J Graff, T Gregersen, A Zaremba, T Borup Andersen, C Nøjgaard, HB Timm, D Rainteau, SH Hansen, JJ Rumessen, LK Munck

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading